Getinge AB (OSTO:GETI B) Total Payout Ratio : 0.33 (As of Jun. 11, 2024)

View and export this data going back to 1998. Start your Free Trial

What is Getinge AB Total Payout Ratio?

Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income.

Getinge AB's current Total Payout Ratio is 0.33.

Getinge AB Total Payout Ratio Historical Data

The historical data trend for Getinge AB's Total Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Getinge AB Total Payout Ratio Chart

Getinge AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Payout Ratio

Get a 7-Day Free Trial

0.13

0.09

0.20

0.31

0.32

Getinge AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Payout Ratio	Get a 7-Day Free Trial															-	3.06	0.01	-	-

Competitive Comparison of Getinge AB's Total Payout Ratio

For the Medical Devices subindustry, Getinge AB's Total Payout Ratio, along with its competitors' market caps and Total Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Getinge AB's Total Payout Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Getinge AB's Total Payout Ratio distribution charts can be found below:

* The bar in red indicates where Getinge AB's Total Payout Ratio falls into.

Getinge AB Total Payout Ratio Calculation

Total Payout Ratio is a measurement showing the proportion of earnings a company pays shareholders in the form of dividends and net stock repurchases.

Getinge AB's Total Payout Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Total Payout Ratio	=	- (Repurchase of Stock	+	Issuance of Stock	+	Cash Flow for Dividends)	/	Net Income
	=	- (0	+	0	+	-1181)	/	3736
	=	0.32

Getinge AB's Total Payout Ratio for the quarter that ended in Mar. 2024 is calculated as

Total Payout Ratio	=	- (Repurchase of Stock	+	Issuance of Stock	+	Cash Flow for Dividends)	/	Net Income
	=	- (0	+	0	+	0)	/	755
	=	0.00

Getinge AB Total Payout Ratio Related Terms

Thank you for viewing the detailed overview of Getinge AB's Total Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Getinge AB (OSTO:GETI B) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Getinge AB (OSTO:GETI B) » Definitions » Total Payout Ratio

Comparable Companies

Traded in Other Exchanges

GNGBY:USA GNGBF:USA GETIBs:UK 0GZV:UK GTN:Germany

Address

Lindholmspiren 7A, P.O. Box 8861, Gothenburg, SWE, SE-417 56

Website

https://www.getinge.com

Getinge, headquartered in Gothenburg, Sweden, manufactures a wide range of products for use in acute care, surgical, and life sciences in the hospital, pharmaceutical, and research settings. The company reports in three segments: acute care therapies (54% of revenue), surgical workflows (32%), and life sciences (14%). Product areas include ventilators, surgical stents, life support systems, sterilizers, surgical tables, and sterile transfer systems. Getinge derives revenue from a broad geographic footprint, with the Americas accounting for 45% of sales (U.S. 33% of sales), Asia-Pacific 25%, and Europe, Middle East, and Africa the remaining 30%.

Getinge AB (OSTO:GETI B) Headlines

No Headlines